Anchoring of vascular endothelial growth factor to surface-immobilized heparin on pancreatic islets: Implications for stimulating islet angiogenesis

Tissue Engineering - Part A

Volumn 16, Issue 3, 2010, Pages 961-970

  Cabric, Sanja ^a   Sanchez, Javier ^a   Johansson, Ulrika ^a   Larsson, Rolf ^a,b   Nilsson, Bo ^a   Korsgren, Olle ^a   Magnusson, Peetra U ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b Corline System AB ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; BLOOD VESSEL PROSTHESES; ENDOTHELIAL CELLS; GLASS; OXIDE MINERALS; PEPTIDES; QUARTZ; SELF ASSEMBLY;

ANGIOGENESIS; ANGIOGENIC GROWTH FACTORS; COATED GLASS; COATED SURFACE; ENGRAFTMENT; GLASS SURFACES; GRAFT FUNCTIONS; IN-VITRO; INNATE IMMUNE SYSTEMS; INSULIN RELEASE; ISLET TRANSPLANTATION; PANCREATIC ISLET; QUARTZ CRYSTAL MICROBALANCE WITH DISSIPATION MONITORING; REVASCULARIZATION; VASCULAR ENDOTHELIAL GROWTH FACTOR;

POLYSACCHARIDES;

BIOMATERIAL; HEPARIN; INSULIN; SILICON DIOXIDE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL SHAPE; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; METABOLISM; PANCREAS ISLET; PROTEIN BINDING; SURFACE PROPERTY; VASCULARIZATION;

CELL PROLIFERATION; CELL SHAPE; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; ENDOTHELIAL CELLS; HEPARIN; HUMANS; INSULIN; ISLETS OF LANGERHANS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN BINDING; QUARTZ; SURFACE PROPERTIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77649261276     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0429     Document Type: Article

References (54)

1. Ryan, E.A., Paty, B.W., Senior, P.A., Bigam, D., Alfadhli, E., Kneteman, N.M., Lakey, J.R., and Shapiro, A.M. Five-year follow-up after clinical islet transplantation. Diabetes 54, 2060, 2005.
2. Rother, K.I., and Harlan DM. Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest 114, 877, 2004.
3. Shapiro, A.M., Ricordi, C, Hering, B.J., Auchincloss, H., Lindblad, R., Robertson, R.P., Secchi, A., Brendel, M.D., Berney, T., Brennan, D.C., Cagliero, E., Alejandro, R., Ryan, E.A., DiMercurio, B., Morel, P., Polonsky, K.S., Reems, J.A., Bretzel, R.G., Bertuzzi, F., Froud, T., Kandaswamy, R., Sutherland, D.E., Eisenbarth, G., Segal, M., Preiksaitis, J., Korbutt, G.S., Barton, F.B., Viviano, L., Seyfert-Margolis, V., Bluestone, J., and Lakey, J.R. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355, 1318, 2006.
4. Jansson, L., and Carlsson, P.O. Graft vascular function after transplantation of pancreatic islets. Diabetologia 45, 749, 2002.
5. Mattsson, G., Jansson, L., and Carlsson, P.O. Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes 51, 1362, 2002.
6. Carlsson, P.O., Palm, F., Andersson, A., and Liss, P. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 50, 489, 2001.
7. Stagner, J.I., and Samols, E. Induction of angiogenesis by growth factors: relevance to pancreatic islet transplantation. EXS 61, 381, 1992.
8. Zhang, N., Richter, A., Suriawinata, J., Harbaran, S., Alto-monte, J., Cong, L., Zhang, H., Song, K., Meseck, M., Bromberg, J., and Dong, H. Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes 53, 963, 2004.
9. Lai, Y., Schneider, D., Kidszun, A., Hauck-Schmalenberger, I., Breier, G., Brandhorst, D., Brandhorst, H., Iken, M., Brendel, M.D., Bretzel, R.G., and Linn, T. Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation 79, 1530, 2005.
10. Hayek, A., Lopez, A.D., and Beattie, G.M. Angiogenic peptides in pancreatic islet transplantation to diabetic rats. Transplantation 50, 931, 1990.
11. Hayek, A., Beattie, G.M., Lopez, A.D., and Chen, P. The use of digital image processing to quantitate angiogenesis induced by basic fibroblast growth factor and transplanted pancreatic islets. Microvasc Res 41, 203, 1991.
12. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C, Declercq, C, Pawling, J., Moons, L., Collen, D., Risau, W., and Nagy, A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435, 1996.
13. Risau, W. Mechanisms of angiogenesis. Nature 386,671,1997.
14. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843, 1992.
15. Forsythe, J.A., Jiang, B.H., Iyer, N.V., Agani, F., Leung, S.W., Koos, R.D., and Semenza, G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16, 4604, 1996.
16. Ferrara, N., Gerber, H.P., and LeCouter, J. The biology of VEGF and its receptors. Nat Med 9, 669, 2003.
17. Leung, D.W., Cachianes, G., Kuang, W.J., Goeddel, D.V., and Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306, 1989.
18. Kuroda, M., Oka, T., Oka, Y., Yamochi, T., Ohtsubo, K., Mori, S., Watanabe, T., Machinami, R., and Ohnishi, S. Co-localization of vascular endothelial growth factor (vascular permeability factor) and insulin in pancreatic islet cells. J Clin Endocrinol Metab 80, 3196, 1995.
19. Christofori, G., Naik, P., and Hanahan, D. Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis. Mol Endocrinol 9, 1760, 1995.
20. Inoue, M., Hager, J.H., Ferrara, N., Gerber, H.P., and Hanahan, D. VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis. Cancer Cell 1, 193, 2002.
21. Gorden, D.L., Mandriota, S.J., Montesano, R., Orci, L., and Pepper, M.S. Vascular endothelial growth factor is increased in devascularized rat islets of Langerhans in vitro. Transplantation 63, 436, 1997.
22. Vasir, B., Aiello, L.P., Yoon, K.H., Quickel, R.R., Bonner-Weir, S., and Weir, G.C. Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes 47, 1894, 1998.
23. Lammert, E., Gu, G., McLaughlin, M., Brown, D., Brekken, R., Murtaugh, L.C., Gerber, H.P., Ferrara, N., and Melton, D.A. Role of VEGF-A in vascularization of pancreatic islets. Curr Biol 13, 1070, 2003.
24. Lukinius, A., Jansson, L., and Korsgren, O. Ultrastructural evidence for blood microvessels devoid of an endothelial cell lining in transplanted pancreatic islets. Am J Pathol 146,429, 1995.
25. Roberts, W.G., and Palade, G.E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108, 2369, 1995.
26. Kristensen, E.M., Rensmo, H., Larsson, R., and Siegbahn, H. Characterization of heparin surfaces using photoelectron spectroscopy and quartz crystal microbalance. Biomaterials 24, 4153, 2003.
27. Cabric, S., Sanchez, J., Lundgren, T., Foss, A., Felldin, M., Kallen, R., Salmela, K., Tibell, A., Tufveson, G., Larsson, R., Korsgren, O., and Nilsson, B. Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes 56, 2008, 2007.
28. Magnusson, P.U., Ronca, R., Dell'Era, P., Carlstedt, P., Jakobsson, L., Partanen, J., Dimberg, A., and Claesson-Welsh, L. Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development. Arterioscler Thromb Vase Biol 25, 944, 2005.
29. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13, 9, 1999.
30. Cross, M.J., and Claesson-Welsh, L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 22, 201, 2001.
31. Flaumenhaft, R., Moscatelli, D., Saksela, O., and Rifkin, D.B. Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. J Cell Physiol 140, 75, 1989.
32. Rapraeger, A.C., Krufka, A., and Olwin, B.B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252, 1705, 1991.
33. Salmivirta, M., Lidholt, K., and Lindahl, U. Heparan sulfate: a piece of information. FASEB J 10, 1270, 1996.
34. Casu, B., and Lindahl, U. Structure and biological interactions of heparin and heparan sulfate. Adv Carbohydr Chem Biochem 57, 159, 2001.
35. Brandhorst, H., Brandhorst, D., Brendel, M.D., Hering, B.J., and Bretzel, R.G. Assessment of intracellular insulin content during all steps of human islet isolation procedure. Cell Transplant 7, 489, 1998.
36. Ricordi, C, Lacy, P.E., and Scharp, D.W. Automated islet isolation from human pancreas. Diabetes 38, 140, 1989.
37. Lakey, J.R., Warnock, G.L., Shapiro, A.M., Korbutt, G.S., Ao, Z., Kneteman, N.M., and Rajotte, R.V. Intraductal collage-nase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant 8, 285, 1999.
38. Andersson, J., Sanchez, J., Ekdahl, K.N., Elgue, G., Nilsson, B., and Larsson, R. Optimal heparin surface concentration and antithrombin binding capacity as evaluated with human non-anticoagulated blood in vitro. J Biomed Mater Res 67, 458, 2003.
39. Goto, M., Eich, T.M., Felldin, M., Foss, A., Kallen, R., Sal-mela, K., Tibell, A., Tufveson, G., Fujimori, K., Engkvist, M., and Korsgren, O. Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture. Transplantation 78, 1367, 2004.
40. Johansson, U., Rasmusson, I., Niclou, S.P., Forslund, N., Gustavsson, L., Nilsson, B., Korsgren, O., and Magnusson, P.U. Formation of composite endothelial cell-mesenchymal stem cell islets: a novel approach to promote islet revascularization. Diabetes 57, 2393, 2008.
41. Johansson, U., Elgue, G., Nilsson, B., and Korsgren, O. Composite islet-endothelial cell grafts: a novel approach to counteract innate immunity in islet transplantation. Am J Transplant 5, 2632, 2005.
42. Faucheux, N., Tzoneva, R., Nagel, M.D., and Groth, T. The dependence of fibrillar adhesions in human fibroblasts on substratum chemistry. Biomaterials 27, 234, 2006.
43. Mitsi, M., Forsten-Williams, K., Gopalakrishnan, M., and Nugent, M.A. A catalytic role of heparin within the extracellular matrix. J Biol Chem 283, 34796, 2008.
44. Mitsi, M., Hong, Z., Costello, C.E., and Nugent, M.A. Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites. Biochemistry 45, 10319, 2006.
45. Daramola, O.A., Heyderman, R.S., Klein, N.J., Shennan, G.I., and Levin, M. Detection of fibronectin expression by human endothelial cells using a enzyme-linked immunosorbent assay (ELISA): enzymatic degradation by activated plasminogen. J Immunol Methods 202, 67, 1997.
46. Larsson, R., Eriksson, J.C., Lagergren, H., and Olsson, P. Platelet and plasma coagulation compatibility of heparin-ized and sulphated surfaces. Thromb Res 15, 157, 1979.
47. Letourneur, D., Machy, D., Pelle, A., Marcon-Bachari, E., D'Angelo, G., Vogel, M., Chaubet, F., and Michel, J.B. Heparin and non-heparin-like dextrans differentially modulate endothelial cell proliferation: in vitro evaluation with soluble and crosslinked polysaccharide matrices. J Biomed Mater Res 60, 94, 2002.
48. Nojiri, C, Noishiki, Y., and Koyanagi, H. Aorta-coronary bypass grafting with heparinized vascular grafts in dogs. A preliminary study. J Thorac Cardiovasc Surg 93, 867, 1987.
49. Chupa, J.M., Foster, A.M., Sumner, S.R., Madihally, S.V., and Matthew, H.W. Vascular cell responses to polysaccharide materials: in vitro and in vivo evaluations. Biomaterials 21, 2315, 2000.
50. Wu, M.H., Guo, M., Yuan, S.Y., and Granger, H.J. Focal adhesion kinase mediates porcine venular hyperpermeabil-ity elicited by vascular endothelial growth factor. J Physiol 552, 691, 2003.
51. Narang, A.S., Cheng, K., Henry, J., Zhang, C, Sabek, O., Fraga, D., Kotb, M., Gaber, A.O., and Mahato, R.I. Vascular endothelial growth factor gene delivery for revascularization in transplanted human islets. Pharm Res 21, 15, 2004.
52. Cabric, S., Elgue, G., Nilsson, B., Korsgren, O., and Schmidt, P. Adenovirus-mediated expression of the anticoagulant hirudin in human islets: a tool to make the islets biocompatible to blood. Cell Transplant 15, 759, 2006.
53. Zhang, N., Schroppel, B., Chen, D., Fu, S., Hudkins, K.L., Zhang, H., Murphy, B.M., Sung, R.S., and Bromberg, J.S. Adenovirus transduction induces expression of multiple chemokines and chemokine receptors in murine beta cells and pancreatic islets. Am J Transplant 3, 1230, 2003.
54. Olsson, R., Maxhuni, A., and Carlsson, P.O. Revascularization of transplanted pancreatic islets following culture with stimulators of angiogenesis. Transplantation 82, 340, 2006.